Sage Journals: Discover world-class research

Free access

Review article

First published 2012-7

Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment

Carrie Hersh, Alex Rae-Grant

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2017-12

Randomized,Placebo-controlled Crossover Study of Dalfampridine Extended-release in Transverse Myelitis

Kateryna Schwartz, Nicholas F Wymbs, Hwa Huang [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2020-09-24

A double-blind,randomized,controlled study of two dose strengths of dalfampridine extended release on walking deficits in ischemic stroke

Stephen J. Page, Scott E. Kasner, Marcia Bockbrader [...]

Restorative Neurology and Neuroscience

Free access

Review article

First published 2011-3

Treatment of walking impairment in multiple sclerosis with dalfampridine

Andrew R. Blight

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2014-1

Assessing dalfampridine efficacy in the physician’s office

JB Raffel, O Malik, RS Nicholas

Multiple Sclerosis Journal

Open access

Research article

First published 2015-9

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

Andrew D Goodman, Francois Bethoux, Theodore R Brown [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2014-5

Dalfampridine improves walking speed,walking endurance,and community participation in veterans with multiple sclerosis: a longitudinal cohort study

Michelle H Cameron, Mary Fitzpatrick, Shannon Overs [...]

Multiple Sclerosis Journal

Retricted access

Case report

First published 2019-4

De novo convulsive status epilepticus in patients with multiple sclerosis treated with dalfampridine

Emilie Panicucci, Mikael Cohen, Veronique Bourg [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2016-2

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

Raymond Hupperts, Jan Lycke, Christine Short [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2016-6

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

Richard Macdonell, Guy Nagels, David-Axel Laplaud [...]

Multiple Sclerosis Journal

Search results